Publication | Closed Access

Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia

Cell DeathSocial SciencesOxidative StressNeuroinflammationBrain InjuryNeurologyGlycogen SynthaseNeuropharmacologyNeuroprotectionCerebral Blood FlowReperfusion InjuryPharmacologyNeurodegenerative DiseasesNeurophysiologyInhibitor Chir025NeuroscienceOxygen-glucose DeprivationMolecular NeurobiologyMedicine